UK Approves Astrazeneca/Oxford COVID-19 Vaccine

A coronavirus vaccine developed by drug firm AstraZeneca and Oxford University has been approved for use in Britain, the government said Wednesday, adding the mass rollout will start on January 4.

The vaccine can be stored, transported and handled at normal refrigerated conditions, and is therefore cheaper and easier to administer than the Pfizer/BioNTech and Moderna jabs that require freezing.

Britain will become the first nation to roll out the jab on January 4, Health Secretary Matt Hancock said, amid mounting concerns that another dangerous spike in infections threatens to overwhelm the NHS.

“Brilliant to end 2020 with such a moment of hope,” tweeted Hancock.

“The #coronavirus vaccine is our way out of the pandemic — now we need to hold our nerve while we get through this together.”

The government said in a statement earlier that it had “today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use.

“This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness,” said the Department of Health and Social Care spokesman.

On Sunday, AstraZeneca’s Chief Executive Pascal Soriot said the vaccine provides “100 percent protection” against severe COVID disease requiring hospitalisation.

He predicted trials would show his firm had achieved a vaccine efficacy equal to Pfizer-BioNTech at 95 per cent and Moderna at 94.5 per cent.

Earlier trials had shown varying outcomes in the AstraZeneca shot’s efficacy.

The vaccine intially showed an average 70 per cent effectiveness but that level jumped to 90 per cent depending on the dosage regime.

Behind this average figure from large-scale trials in the UK and Brazil was a 62 percent effectiveness for those who were vaccinated with two full doses of the shot.

For volunteers who received a half-dose first and then a full dose one month later, however, the vaccine was found to have 90 per cent efficacy.

  • Related Posts

    154 students hospitalised over suspected drug reaction in Katsina

        One hundred and fifty-four students of Government Science Secondary School, Batagarawa, Katsina State, were hospitalised following a suspected adverse reaction to praziquantel tablets administered to treat bilharzia.  …

    Suspected Fake Surgeon Arrested In Rivers State, Eight Facilities Sealed

      The Rivers State Ministry of Health has sealed eight additional health facilities and arrested four persons for alleged medical quackery, impersonation, and operating without registration. The enforcement exercise, conducted…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nigerian Man Sentenced to 24 Months in US for Aggravated Identity Theft

    • By admin
    • November 21, 2026
    • 2 views
    Nigerian Man Sentenced to 24 Months in US for Aggravated Identity Theft

    Terrorists bomb high voltage lines linking Kainji Dam to Jebba

    • By admin
    • November 21, 2026
    • 3 views
    Terrorists bomb high voltage lines linking Kainji Dam to Jebba

    Mexico arrests FBI most-wanted drug lord Chapo Isidro

    • By admin
    • November 21, 2026
    • 9 views
    Mexico arrests FBI most-wanted drug lord Chapo Isidro

    NCoS releases names, photos of two fleeing death-row inmates in Kwara

    • By admin
    • November 21, 2026
    • 10 views
    NCoS releases names, photos of two fleeing death-row inmates in Kwara

    Police Recover Bodies Of Two Abducted Victims In Edo

    • By admin
    • November 21, 2026
    • 4 views
    Police Recover Bodies Of Two Abducted Victims In Edo

    Imo police hunt man for killing girlfriend

    • By admin
    • November 21, 2026
    • 6 views
    Imo police hunt man for killing girlfriend